News

Eisai has launched Lusedra (fospropofol disodium) injection CIV for use by persons trained in the administration of general anesthesia. Lusedra, an aqueous solution, is an intravenous sedative-hypnotic agent

Cmed has announced the opening of its second US office in Durham, North Carolina. The company said the new office is established to meet the needs of the

AstraZeneca has announced results of a PLATO sub-analysis in Acute Coronary Syndrome (ACS) patients, those with ST Segment Elevation Myocardial Infarction (STEMI). The sub-analysis showed that, compared to

Novo Nordisk has inaugurated a new facility with a capacity of 26 million vials per annum in partnership with Torrent Pharmaceuticals. Jesper Hoiland, senior vice president of international

Torrent Pharma has announced its plans to invest in Dahej SEZ, India, reported Business Standard. The company is also eying the US from its facility in Dahej and

Addex has achieved statistically significant efficacy on the primary endpoint, increasing the number of symptom free days in the Phase IIb trial of ADX10059 as a monotherapy in

US subsidiary of Glenmark, Glenmark Generics has announced that it has settled all litigation pending between Glenmark and Medicis. The litigation were regarding the patent actions of Fluocinonide,

In one project, the National Human Genome Research Institute (NHGRI) will support work at ASU’s Biodesign Institute through a significant grant to boost research on rapid DNA sequencing

“We are very grateful and appreciative for ADDF’s support,” reported Dr. Joel Braunstein, managing member of C2N. “Beginning in 2008, ADDF provided funding to us at a vital